Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gesina, E.
Right arrow Articles by Breant, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gesina, E.
Right arrow Articles by Breant, B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:2322-2329, 2004
© 2004 by the American Diabetes Association, Inc.

Dissecting the Role of Glucocorticoids on Pancreas Development

Emilie Gesina1, François Tronche2, Pedro Herrera3, Belinda Duchene1, Willemène Tales1, Paul Czernichow1, and Bernadette Breant1

1 Institut National de la Santé et de la Recherche Médicale (INSERM) U457, Hôpital Robert Debré, Paris, France
2 Centre National de la Recherche Scientifique FRE 2401, Collège de France, Paris, France
3 Department of Morphology, University of Geneva Medical School, Geneva, Switzerland

To determine whether glucocorticoids are involved in pancreas development, glucocorticoid treatment of rat pancreatic buds in vitro was combined with the analysis of transgenic mice lacking the glucocorticoid receptor (GR) in specific pancreatic cells. In vitro treatment of embryonic pancreata with dexamethasone, a glucocorticoid agonist, induced a decrease of insulin-expressing cell numbers and a doubling of acinar cell area, indicating that glucocorticoids favored acinar differentiation; in line with this, expression of Pdx-1, Pax-6, and Nkx6.1 was downregulated, whereas the mRNA levels of Ptf1-p48 and Hes-1 were increased. The selective inactivation of the GR gene in insulin-expressing ß-cells in mice (using a RIP-Cre transgene) had no measurable consequences on ß- or {alpha}-cell mass, whereas the absence of GR in the expression domain of Pdx-1 (Pdx-Cre transgene) led to a twofold increased ß-cell mass, with increased islet numbers and size but normal {alpha}-cell mass in adults. These results demonstrate that glucocorticoids play an important role in pancreatic ß-cell lineage, acting before hormone gene expression onset and possibly also modulating the balance between endocrine and exocrine cell differentiation.


Address correspondence and reprint requests to Bernadette Breant, INSERM U457, Hôpital Robert Debré, Paris F 75019, France. E-mail: bernadette.breant{at}rdebre.inserm.fr


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
J. A. Owens, K. L. Gatford, M. J. De Blasio, L. J. Edwards, I. C. McMillen, and A. L. Fowden
Restriction of placental growth in sheep impairs insulin secretion but not sensitivity before birth
J. Physiol., November 1, 2007; 584(3): 935 - 949.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Gartner, G. Vila, T. Daneva, A. Nabokikh, F. Koc-Saral, A. Ilhan, O. Majdic, A. Luger, and L. Wagner
New functional aspects of the neuroendocrine marker secretagogin based on the characterization of its rat homolog
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E347 - E354.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Mairesse, J. Lesage, C. Breton, B. Breant, T. Hahn, M. Darnaudery, S. L. Dickson, J. Seckl, B. Blondeau, D. Vieau, et al.
Maternal stress alters endocrine function of the feto-placental unit in rats
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1526 - E1533.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-Y. Lee, M. Ristow, X. Lin, M. F. White, M. A. Magnuson, and L. Hennighausen
RIP-Cre Revisited, Evidence for Impairments of Pancreatic beta-Cell Function
J. Biol. Chem., February 3, 2006; 281(5): 2649 - 2653.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A L Fowden, D S Gardner, J C Ousey, D A Giussani, and A J Forhead
Maturation of pancreatic {beta}-cell function in the fetal horse during late gestation
J. Endocrinol., September 1, 2005; 186(3): 467 - 473.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. W. Limesand, J. Jensen, J. C. Hutton, and W. W. Hay Jr.
Diminished {beta}-cell replication contributes to reduced {beta}-cell mass in fetal sheep with intrauterine growth restriction
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1297 - R1305.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.